Here is the summary of concerns for SGI based on end of year report:
AISC increases by 48% $2091 ( USD) ! (How can they make money?)
Cash equivalents of $8.1 million end Q4 ( note: only equivalents, where is the cash?)
Secured an AUD$10 million debt financing with Auramet International on October 7, 2022.
On March 30, 2023, the Company announced it had entered into a CAD$5 million bridge loan with Auramet International.
Operation loss $16.1 million and Net loss $14.2 million (USD) for the year - Ouch !
Jeezs Henty looks like a Picasso compared to this finger painting.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report
Here is the summary of concerns for SGI based on end of year...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYL (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
-0.050(4.31%) |
Mkt cap ! $249.2M |
Open | High | Low | Value | Volume |
$1.17 | $1.17 | $1.11 | $353.0K | 312.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 307 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.15 | 1720 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 307 | 1.110 |
2 | 3376 | 1.105 |
2 | 3876 | 1.100 |
2 | 9376 | 1.095 |
1 | 1376 | 1.090 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 1720 | 1 |
1.155 | 1720 | 1 |
1.160 | 10124 | 3 |
1.170 | 3356 | 2 |
1.175 | 12000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
CYL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online